Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
Sales 2020 | 304M 326M | Sales 2021 | 328M 352M | Capitalization | 724M 777M |
---|---|---|---|---|---|
Net income 2020 | 33M 35.41M | Net income 2021 | 60M 64.38M | EV / Sales 2020 | 3.16 x |
Net Debt 2020 | 237M 255M | Net Debt 2021 | 249M 267M | EV / Sales 2021 | 2.97 x |
P/E ratio 2020 |
21.5
x | P/E ratio 2021 |
11.9
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Amer Jaber
COO | Chief Operating Officer | - | 18-12-31 |
Daniel Smith
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-10 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nunzio Antonelli
BRD | Director/Board Member | - | 15-11-09 |
Nicola Lamacchia
BRD | Director/Board Member | - | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+3.92% | 69.91B | |
+10.97% | 9.03B | |
-17.03% | 4.75B | |
+37.51% | 4.31B | |
+3.92% | 3.88B | |
+17.05% | 2.37B | |
-24.13% | 2.26B | |
-29.70% | 2.2B | |
+9.09% | 1.98B |
- Stock Market
- Equities
- STAGR Stock